Stock DNA
Pharmaceuticals & Biotechnology
JPY 3,089 Million (Micro Cap)
40.00
NA
0.00%
0.10
6.23%
1.00
Revenue and Profits:
Net Sales:
2,085 Million
(Quarterly Results - Jun 2025)
Net Profit:
24 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.15%
0%
-5.15%
6 Months
10.35%
0%
10.35%
1 Year
38.94%
0%
38.94%
2 Years
21.8%
0%
21.8%
3 Years
24.23%
0%
24.23%
4 Years
-16.15%
0%
-16.15%
5 Years
-41.52%
0%
-41.52%
PLATZ Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.25%
EBIT Growth (5y)
-23.50%
EBIT to Interest (avg)
20.26
Debt to EBITDA (avg)
1.59
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
1.30
Tax Ratio
69.09%
Dividend Payout Ratio
32.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.26%
ROE (avg)
9.99%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
0.85
EV to EBIT
22.61
EV to EBITDA
12.57
EV to Capital Employed
0.87
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.86%
ROE (Latest)
2.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
2,084.50
2,273.20
-8.30%
Operating Profit (PBDIT) excl Other Income
46.90
130.20
-63.98%
Interest
5.40
5.20
3.85%
Exceptional Items
0.00
0.00
Consolidate Net Profit
24.20
89.10
-72.84%
Operating Profit Margin (Excl OI)
4.50%
41.10%
-3.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -8.30% vs 8.56% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -72.84% vs 90.79% in Mar 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
8,422.70
6,387.50
31.86%
Operating Profit (PBDIT) excl Other Income
323.50
106.30
204.33%
Interest
18.90
11.00
71.82%
Exceptional Items
0.00
7.50
-100.00%
Consolidate Net Profit
193.00
65.70
193.76%
Operating Profit Margin (Excl OI)
21.80%
5.90%
1.59%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 31.86% vs 1.19% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 193.76% vs -70.46% in Jun 2024
About PLATZ Co., Ltd. 
PLATZ Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






